Prior to speaking at the Festival in June, Christensen tell us it’s a challenge trying to make the greatest impact on developing novel cancer agents while consuming the smallest amount of resources
Said Ismail is bringing precision medicine to the Arab population, setting a global example
Goldenberg went to medical school at the age of 41, has founded three 22q11 clinics and developed an open social media “forum” on her son’s rare condition
One of the busiest people out there: involved in defining standards for the use of next generation sequencing in clinical diagnostics and more
He has trained over 50 post-docs and grad students as primary advisor, and co-authored over 130 papers. In addition he advice companies within genomics and healthcare. What does this man not do?
With over 25 years of research experience in human molecular genetics, Nick Lench tells us that implementing genomic medicine into everyday clinical practice can be challenging
Liz has been scouring the web, chasing down leads, and writing up a storm to give you the choicest cuts of genomic news and thoroughly readable features
As science develops every day, the community is dependent on those who help inform on ethics and considerations – T. Patrick Hill is one of these contributors
Sarah Teichmann of the Wellcome Trust Sanger Institute, is leading a new charge on human cellular genomics as part of the Human Cell Atlas project
Paediatric geneticist David Flannery became ACMG Medical Director in 2014, bringing with him unique expertise in healthcare economics and genetic services
ACMG’s Judith Benkendorf, genetic counsellor and pioneer of the “counsel-ome”, shares some career highlights in the world of medical genetics
Stephen Kingsmore is leading a powerful charge to make genomic diagnosis of critically ill newborns a standard, straightforward part of clinical practice
Pathologist Valentina Nardi often has to call upon her inner Sherlock Holmes, and make use of both surgical and molecular skills, to make tricky diagnoses
Hayley Robinson shares some of the challenges in bringing advanced molecular diagnostics to healthcare, with the slower pace of policy
Brendan gives us an insight on how it is working at the leading secondary analysis start-ups out there. Ever heard of Genomics Coffee Club?